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Background: The bacteriophage therapy is an effective antimicrobial approach with potentially important
applications in medicine and biotechnology which can be seen as an additional string in the bow. Emerging drug
resistant bacteria in aquaculture industry due to unrestricted use of antibiotics warrants more sustainable and
environmental friendly strategies for controlling fish infections.
The isolated bacteria from fish lesions was characterised based on isolation on selective and differential medium
like Pseudomonas agar, gram staining, biochemical tests and 16SrRNA sequencing. The metallo-beta-lactamase
(MBL) producing bacterial isolate was evaluated using Imipenem - Ethylenediaminetetraacetic acid (EDTA) disk
method. The specific bacteriophage was isolated and concentrated using coal bed developed in our lab at
CSIR-NEERI. The isolated and enriched bacteriophage was characterised by nucleotide sequencing and electron
microscopy. The phage therapy was applied for treating ulcerative lesion in fish.
Results: The pathogenic bacterium responsible for causing ulcerative lesions in catfish species (Clarias gariepinus)
was identified as Pseudomonas aeruginosa. One out of twenty P. aeruginosa isolate showing multi drug resistance
(MDR) was incidentally found to be MBL producing as determined by Imipenem-EDTA disk method. The phage
therapy effectively cured the ulcerative lesions of the infected fish in 8–10 days of treatment, with a sevenfold
reduction of the lesion with untreated infection control.
Conclusion: Bacteriophage therapy can have potential applications soon as an alternative or as a complement to
antibiotic treatment in the aquaculture. We present bacteriophage therapy as a treatment method for controlling
MDR P. aeruginosa infection in C. gariepinus. To the best of our knowledge this is a first report of application of
phage therapy against MBL producing P. aeruginosa isolated from aquatic ecosystem.
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Freshwater aquaculture is one of the major cash crops in
India. Indian freshwater aquacultures are dominated by
the fish species like Clarias gariepinus, Labeo rohita,
Catla catla, and Cirrhinus mrigala. Owning to increase
in aquacultural industries, more environmental friendly
strategies for controlling fish infections are urgently needed
to make the aquaculture industry more sustainable [1,2].
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reproduction in any medium, provided the ormicrobial infections because of various stress conditions
resulting into occurrence of infectious diseases [3].
Aquaculture industries are rapidly progressing to fulfill
food requirement and provide employment opportunities
for growing population. One of the major threatening
problems faced by the aquaculture industries is the devel-
opment of antibiotic-resistant bacterial strains owing to ex-
tensive use of antibiotics, afterwards leading to a financial
loss [4]. Therefore, finding alternative antibacterial agents
to control bacterial diseases caused by antibiotic resistant
bacteria has attracted significant interest.
Carbapenem group of antibiotics are important in the
management of nosocomial gram negative infections, be-
cause of their broad spectrum activity and stability tol Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Isolation of Pseudomonas aerouginosa by cotton swab
from wound of infected Clarias gariepinus.
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tended spectrum β-lactamases (ESBLs). Nosocomial out-
breaks of carbapenem-resistant Pseudomonas aeruginosa
because of metallo-β-lactamase (MBL) production have
been reported from various regions [5-7]. The emergence
of these MBLs in gram negative bacilli is becoming a
therapeutic challenge, as these enzymes have high hydro-
lytic activity that leads to degradation of higher generation
cephalosporin; therefore the treatment alternatives are un-
available, or expensive/toxic with poor outcome [8]. Plas-
mid mediated MBL genes spread rapidly to other species
of gram-negative bacilli; therefore rapid detection of MBL
production is necessary to modify therapy and to begin ef-
fective infection control to prevent their dissemination.
To date there has been few reports from India suggesting
presence of MBL producing isolate [9]. The purpose of
this study was to find an alternative therapy for ulcerative
skin lesions in catfishes of aquaculture industry caused by
multidrug resistant (MDR) P. aeruginosa.
The phage therapy holds potential and can be an
ecofriendly method to control bacterial diseases which
can be seen as additional string in the bow to antibi-
otics and chemotherapy [4,10]. Most bacteriophages from
Siphoviridae family that are mostly lytic are used in phage
therapy [11-14]. The intraperitoneal and orally adminis-
tered phage makes fish immune to their infection, suggest-
ing the potential use of the phage for controlling the
disease [15], similar successful approach were carried out
for animal models showing therapeutic efficacy of phage
therapy [16-25]. Owing to high mutation rate and short
generation time RNA phages (Leviviridae and Cystoviridae)
can prove an important agent for phage therapy which
makes RNA phages to infect several host species [26]. The
mixture of different strains of phages could prevent the
emergence of a resistant strain. Purified phage-encoded en-
zymes and their combinations are effective for the treat-
ment of bacterial infectious diseases [4,27].
The bacteriophage therapy is promising for aquacul-
ture industry in treating bacterial infection of fish; this
approach is new [4,11,12,28-30]. In this study, we show
the effect of bacteriophage therapy on P. aeruginosa in-
fection in freshwater catfish C. gariepinus. C. gariepinus
is an important economic freshwater fish and considered
an excellent model for toxicological studies by various
workers [31-33]. In this pilot study, we show the applica-
tion of bacteriophage in controlling the MDR P. aerugi-
nosa infection in catfish C. gariepinus.
Methods
Selection of experimental fish
The Clarias gariepinus (catfish) weighing about 500 grams
were collected from Sakkardara fish Market, Nagpur
(India). Twenty fishes were selected for the study with
similar sized ulcerative lesions of bacterial skin infection.The experimental research was ethically approved by Ani-
mal Ethics Committee of Maharashtra Animal and Fisher-
ies Sciences University, Nagpur. Ten infected fishes were
subjected to phage therapy treatment and other ten were
spared as untreated an infection control.
Isolation and identification of bacterial cultures
The infected fishes were taken out from the fish tank; then
sterilized cotton swab was rubbed on the infected region
of fishes (Figure 1). Cotton swab was then streaked on nu-
trient agar plate and incubated at 37°C for 24 hours. After
incubation, the isolated colony was enriched in nutrient
broth at 37°C for 24 hours. Pseudomonas was confirmed
from the lesions of twenty infected cat fishes by isolating
the bacteria on selective and differential medium Pseudo-
monas agar (Figure 2). The etiological agent for the lesions
of twenty infected cat fishes was identified as Pseudo-
monas aeruginosa by oxidase test and biochemical reac-
tions. One of the representative Pseudomonas isolate was
further confirmed as P. aeruginosa by denovo nucleotide
sequencing of 16SrRNA, sequence analysis and Basic
Local Alignment Search Tool (BLAST).
Screening of multi drug resistant P. aeruginosa
The organisms were isolated from ulcerative lesions of
twenty infected catfishes. Twenty isolates of P. aeruginosa
showed MDR. A MDR isolate mean resistance to two or
more drugs or drug classes of therapeutic relevance [34].
Pseudomonas aeruginosa ATCC 27853 was used as a nega-
tive control. Susceptibility testing against Clinical Labora-
tory Standards Institute (CLSI) recommended antibiotics
were performed by Kirby Bauer disk diffusion method [9].
The antibiotic susceptibility was further confirmed by de-
termining the minimum inhibitory concentration (MIC)
on agar dilution method as recommended by CLSI. The
routine antibiotic sensitivity tests were put up for amino-
glycosides [amikacin (30 μg), gentamicin (10 μg), netilmicin
(30 μg) and tobramycin (10 μg)], cephalosporins [cefopera-
zone (75 μg), cefepime (30 μg), ceftazidime (30 μg), ceftri-
axone (30 μg) and ceftizoxime (30 μg)], fluoroquinolones
Figure 2 Isolated Pseudomonas aerouginosa on Pseudomonas
agar from the wound of infected Clarias gariepinus.
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cin (10 μg)], carbapenems [imipenem (10 μg) and mero-
penem (10 μg)], chloramphenicol (30 μg), piperacillin/
tazobactam (100/10 μg), aztreonam (30 μg) and colistin
(10 μg). The organisms were susceptible to Imipenem if
MIC was <4 μg/mL and resistant if MIC was ≥16 μg/mL
[9]. Notably out of twenty MDR P. aeruginosa isolates one
showed to be suspected MBL-producing as the isolate was
resistant to meropenem and imipenem. Henceforth, the
isolate was further probed for potential MBL production.
To identify MBL production in this isolate, we used
Imipenem-EDTA disk synergy test developed by Yong D
et al. [35]. Earlier reports have recommended that the
Imipenem-EDTA disk synergy test is a reliable method for
initial screening of MBL production in clinical isolates [9].Figure 3 Isolation of bacteriophages against Pseudomonas
aerouginosa.Isolation and Concentration of Bacteriophage
Isolation and concentration of bacteriophages from waste-
water sample was performed by bituminous coal method
developed at CSIR-NEERI, Nagpur [36,37]. The method is
described briefly as follows; the wastewater sample volume
taken for the concentration of bacteriophage was 300 ml.
The sample was adjusted to pH 6 with 0.1 N HCl, and the
solution of AlCl3 was added to get a final concentration of
0.0005 M of AlCl3. It was then filtered through coal bed.
The filtrate was discarded and bacteriophages adsorbed
on coal bed were eluted with Mcllvaine buffer solution of
pH 7.1 by applying vacuum. The volumes of Mcllvaine
buffer solution used was 15 ml for 30 mm diameter coal
bed. Mcllvaine buffer solution was allowed to slowly passthough the coal bed in 15 minutes. To maximize the
recovery of bacteriophages the eluate was recirculated
through the coal bed once more. The Mcllvaine buffer
solution containing bacteriophage was serially diluted up
to 10-5 concentrations with distilled water to reduce the
phage load to help better isolation of plaques; as naturally
the concentration of the phages is about 105 to 107 per ml
in wastewater. The eluted sample was used for enumer-
ation of phages [37].Isolation and identification of selective Pseudomonas phage
The P. aeruginosa were propagated in the Tryptose Soya
Broth for isolation and propagation of phages in accord-
ance with the method of Clescerl et al., [38]. Bacterio-
phages against the Pseudomonas cultures were successfully
isolated from the wastewater with same methodology men-
tioned above in Isolation and Concentration of Bacterio-
phage [36,38]. The P. aeruginosa specific lytic phages were
isolated in Pseudomonas agar (HiMedia) by plaque assay
in accordance with standard method of American Public
Health Agency (Figure 3). The isolated lytic phages were
then enriched in Tryptose Soya Broth overnight with 24
hours old-culture of P. aeruginosa in accordance with the
method of Clescerl et al., [38]. The phage lysate was then
recovered from the broth by filtering it through 0.22 μm
membrane filter [36,38].Phage genome sequencing and sequence analysis
The phage isolate was further confirmed by DNA extrac-
tion, de-novo nucleotide sequencing, sequence analysis and
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of Lavigne et al., [39].
Nucleotide sequence accession numbers
The bacteriophage nucleotide sequences obtained in this
study was deposited in GenBank with the accession num-
ber [GenBank:KC969441]. The P. aeruginosa nucleotide
sequence obtained in this study was submitted in GenBank
with the accession number [GenBank:KF811604].
Transmission electron microscopic studies
Hundred micro litre of virus/phage suspension was fixed
with 10ul fixative (10% formaldehyde and 5% glutaralde-
hyde in deionized water) to give a final concentration in
the virus/phages suspension of 1% formaldehyde and 0.5%
glutaraldehyde. In a 2 ml Eppendorf tube 10 μl of fixed or
unfixed virus/phages suspension, 10 μl of latex spheres
and 10 μl of 1% bovine serum albumin (BSA) in distilled
water was taken and mixed for 30 minutes. For qualitative
study, no latex spheres are needed. Hold the grid in for-
ceps and apply above suspension on the grid and leave it
on for 30 seconds to 1 minute, then draw off the edge of
the grid with filter paper (watch grid surface to make sure
a thin layer of liquid film is formed). Apply immediately
(before sample is dried) 6–10 μl of 2% aqueous phospho-
tungstic acid (adjust pH to 7.3 using 1 N NaOH) and leave
on for 30 seconds, and draw off the edge of the grid with
filter paper (watch grid surface to make sure a thin layer
of liquid film is formed) and place the grid directly into
grid box and allow them air-dry for several hours or
overnight before observation. Ten fields for each sample
are randomly photographed at 5000× after first examin-
ing the grid for uniformity. The negatives are enlarged
2.5× to a final magnification of 12,500× (http://www.
ihcworld.com/_protocols/em/em_negative.htm).
Phage nucleic acid purification
Phage lysate (1010pfu/mL) was treated with DNase I and
RNase A at 37°C for 15 min to remove any contaminat-
ing free nucleic acids. The phage was then concentrated
and precipitated using 20% polyethylene glycol 8000 (PEG
8000) containing 2 mol/L NaCl, EDTA (to a final concen-
tration of 20 mmol/L), and 0.5% SDS followed by incuba-
tion at 68°C for 5 min. The resulting phage nucleic acid
was purified using a phenol/chloroform phage genome in
accordance with the method of Lavigne et al., [39].
Phage therapy of infected fish
Experiments were carried out on ten infected fishes to
phage therapy treatment and other ten were spared as
untreated an infection control. Phage concentration of 1010
per ml of P. aeruginosa was obtained and was used for ef-
fective treatment of the skin lesions of the cultured C. gar-
iepinus at laboratory level. The phage formulation wasapplied on the infected skin lesion of ten C. gariepinus with
sterile cotton swab. On the contrary, infection control fish
with similar sized infected skin lesion were applied with
phage free diluents to compare with infected fishes under-
going phage therapy. The phage free diluent was applied to
infection control to avoid the effect of a phage diluent pla-
cebo. The water temperature of the fish tanks was 20 ± 1°C
throughout the experiments.
Statistical analysis for phage treatment
Statistical tool like Minitab 16 software free trial version
was applied to perform the statistical analysis of bac-
teriophage treatment on infected Clarias gariepinus.
Results and discussion
Isolation and Characterization of the isolated bacterial
The bacteria from ulcerative skin lesions of twenty in-
fected catfishes were isolated on selective and differential
medium like Pseudomonas agar. The isolated bacterium
was characterized by gram staining, biochemical test and
16SrRNA sequencing as P. aeruginosa. The BLAST results
of nucleotide sequence of Pseudomonas isolate accession
number [GenBank:KF811604] showed 99% identity to other
P. aeruginosa isolates nucleotide submissions in Genbank.
Imipenem-resistance in the isolate of P. aeruginosa was
determined by disc diffusion method. Imipenem-EDTA
disc method showed MBL production in imipenem resist-
ant Pseudomonas aeruginosa isolate (Figure 4A). Imi-
penem sensitive control strain did not show any MBL
production (Figure 4B). Earlier reports suggest that most
of the MBL producing isolates have shown resistance to
other important groups of antibiotics including third-
generation cephalosporin, aminoglycoside and quinolone
[40]. Acquired MBLs may rapidly emerge and establish a
condition of endemicity in certain epidemiological setup
[41]. Reports from various parts of the world showing
emergence of MBL in Enterobacteriaceae is evidence for
the spread of these enzymes in this family [42]. Emergence
of MBLs producing P. aeruginosa in aquatic ecosystem is
alarming and reflects excessive use of antibiotics. There-
fore, early detection and prompt infection control mea-
sures is important to prevent further spread of MBLs to
other gram negative rods. Additionally, it is also important
to follow antibiotic restriction policies to avoid excessive
use of broad-spectrum antibiotics. This is a first report
of application of phage therapy against MBL producing
P. aeruginosa isolated from aquatic ecosystem.
Transmission electron microscopic studies
Ten photographs for each sample are examined for the
number of virus/phages particles and the number of beads.
Beads are recognized as much larger than virus (about 1 ½
times larger). Both beads and virus/phage particles are
marked as they are counted to avoid duplicate counting.
Figure 4 Figure showing Imipenem EDTA disk to test metallo β lactamase (MBL) production, disc 1: Imipenen; disc 2: Imipenem with
EDTA; disc 3: EDTA. A) MBL Negative Pseudomonas aerouginosa ATCC 27853 as control and B) MBL positive Pseudomonas aerouginosa isolate.
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The transmission electron microscopic studies of some
selected isolates were studied for getting some insight of
phage host interaction. The study was done to understand
the process of phage infection process in bacteria. Various
stages during lytic interactions and Pseudomonas phages
were observed through TEM studies as shown in Figures 5.Figure 5 Transmission electron microscopy images of (A) Pseudomon
Pseudomonas aeruginosa at different point of time.Phage genome sequencing and sequence analysis
The Pseudomonas phage MBL sequence accession number
[GenBank:KC969441] was subjected to NCBI-BLAST that
showed following level of identity with other Pseudomonas
phage isolate submissions like 99% identity with Pseudo-
monas phage PT2 accession number [GenBank:EU2364
38.1], 98% identity with Pseudomonas phage phiKMV ac-
cession number [GenBank:AJ505558.1]; and 97% identityas phage head; (B, C and D) Bacteriophage mediated lysis of
Figure 6 A plot of phage therapy. (A) effect on infected Clarias gariepinus. (B) Interaction between the treatment types.
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The ORF prediction was also performed using NCBI’s
Open Reading Frame (ORF) Finder tool available at
http://www.ncbi.nlm.nih.gov/gorf/gorf.html. The Pseudo-
monas phage MBL genome was dsDNA with total length
of 42519 bp having 241 ORFs over 100 bp.Table 1 Analysis of variance (ANOVA) based on treatment typ
infected Clarias gariepinus
Source Degree of freedom Sum
Treatment (Control/treated) 1
Phase (Initial/final) 1
Interaction 1
Error 36
Total 39 1Efficiency of Bacteriophage therapy
The pathogenic microorganisms cause diseases in im-
portant wild fish species [43-50]. Owing to frequent use
of antibiotics and high replication and fast mutation rate
in microbial community, most pathogens had become
resistant to the antibiotics making their treatments inef-
fective and help them survive besides an antibiotic drug.e and treatment phases of phage therapy effect on
of square Mean square F P
416.02 416.025 71.63 <0.001
378.23 378.225 65.12 <0.001
225.63 225.625 38.85 <0.001
209.10 5.808
228.97
Figure 7 Representative image of (A) infected Clarias gariepinus without phage treatment; (B) infected Clarias gariepinus subjected to
phage treatment.
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pathogens forms an important threat to public health
[51]. The antibiotic resistant genes are responsible for
antibiotic resistant bacteria in fish farming plants and
other environments [52]. In contrast to disease preven-
tion, the antibiotics are also used as growth promoters
in fish farms [4]. The conventional disinfectants like
humic acids, formaldehyde, formalin, sodium chloride,
iodine considered to be an option are now restrained in
several countries as they are carcinogenic and have ad-
verse effect on environment [53-55].
Our results showed that phage therapy could be effect-
ively used in curing the skin lesions of the diseased fish
in 8–10 days, as experimentally observed in ten infected
fishes subjected to phage therapy with about sevenfold
reduction of the lesion with compared to phage untreated
infection control fishes. A box plot of phage therapy effect
on infected Clarias gariepinus is shown in Figure 6A. The
interaction plot shows that there is significant difference
between the treatment types that is phage untreated vs
phage treated (P <0.001) as shown in Figure 6B. The confi-
dence Interval 99% and the P <0.001 of results, suggest that
the treatment type and treatment phases (initial/final) are
statistically significant (Table 1). A representative image of
infected Clarias gariepinus with and without phage treat-
ment as shown in Figure 7A and B respectively.Future prospective
This study clearly indicates that phages are effective thera-
peutic agents against bacterial infections not only in fishes,
but also have potential applications in the treatment of
other animals including human beings [4,15,18,20]. Ex-
tensive studies have been done recently looking at theapplications of phage therapy in the aquacultural disease
control. The possible limitation for phage therapy is tem-
perate phages transferring antibiotic resistance genes and
virulence factors to the bacteria, transforming nonpatho-
genic strains into pathogenic strains. Before using phages
for phage therapy it would be important to test whether
phages carry any virulence genes [4,56-61]. The other dis-
advantages include time consuming and host resistance
because of lysogen formation. However, they can be mini-
mized by use of selective lytic phages against the patho-
gens and by application of phage enzymes or combined
application of phage enzymes [37] against the host cell
components as they can effectively lyse the infecting bac-
teria. Moreover, for the commercial application of phage
therapy, it is necessary to carry out further studies about
its efficiency for bacterial disinfection.Conclusion
Bacteriophage therapy can have potential applications
soon as an alternative or as a complement to antibiotic
treatment in the aquaculture. We present bacteriophage
therapy as a treatment method for controlling MDR P.
aeruginosa infection in C. gariepinus. To the best of our
knowledge this is a first report of application of phage
therapy against MBL producing P. aeruginosa isolated
from aquatic ecosystem.
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